[Training effects on pain in rheumatoid arthritis]
- PMID: 12822009
[Training effects on pain in rheumatoid arthritis]
Abstract
Background: This report considers the relationship between the effect of training on pain and joint manifestations in patients with rheumatoid arthritis.
Methods: A review of randomized controlled trials published from 1997 to February 2001.
Results: Six randomized controlled trials confirm results from previous research indicating that exercise leads to unchanged or reduced self-reported pain and unchanged or reduced tender joint counts in patients in ACR functional classes I or II with low to moderate disease activity. This effect may possibly be generalized to patients with higher disease activity. The effect is less clearly demonstrated in patients with serious joint destruction and loss of function.
Interpretation: The results indicate that exercise leads to unchanged or reduced self-reported pain and joint tenderness for patients with rheumatoid arthritis. Further studies are needed in order to demonstrate to what extent and how different kinds of exercise influence pain and joint tenderness in rheumatoid arthritis patients.
Similar articles
-
Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III.J Rheumatol. 1997 Aug;24(8):1531-9. J Rheumatol. 1997. PMID: 9263147 Clinical Trial.
-
Self-administered joint counts in rheumatoid arthritis: comparison with standard joint counts.J Rheumatol. 1999 Mar;26(3):536-9. J Rheumatol. 1999. PMID: 10090158
-
Predictors of exercise and effects of exercise on symptoms, function, aerobic fitness, and disease outcomes of rheumatoid arthritis.Arthritis Rheum. 2007 Aug 15;57(6):943-52. doi: 10.1002/art.22903. Arthritis Rheum. 2007. PMID: 17665488 Clinical Trial.
-
Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.Bull NYU Hosp Jt Dis. 2008;66(3):216-23. Bull NYU Hosp Jt Dis. 2008. PMID: 18937635 Review.
-
Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.Clin Ther. 2004 Dec;26(12):1960-75. doi: 10.1016/j.clinthera.2004.12.019. Clin Ther. 2004. PMID: 15823761 Review.